Chalew S, Gomez R, Vargas A, Kamps J, Jurgen B, Scribner R, Hempe J Hemoglobin A1c, frequency of glucose testing and social disadvantage: Metrics of racial health disparity in youth with type 1 diabetes. J Diabetes Complications. 2018 Dec;32(12):1085-1090. doi: 10.1016/j.jdiacomp.2018.02.008. Epub 2018 Aug 10.
Chalew S, Hamdan M Racial disparity in HbA1c persists when fructosamine is used as a surrogate for mean blood glucose in youth with type 1 diabetes. Pediatr Diabetes. 2018 Nov;19(7):1243-1248. doi: 10.1111/pedi.12696. Epub 2018 Aug 21.
Chalew SA, Harrison J, Berry S Achievement of glycemic outcome goals in pediatric diabetes: the impact of staff number. J La State Med Soc. 2008 Nov-Dec;160(6):328-32.
Chalew SA The continuing challenge of outcome disparities in children with diabetes. Pediatrics. 2015 Mar;135(3):552-3. doi: 10.1542/peds.2014-4136.
Dias RP, Brown F, Wyatt C, Cheema S, Allgrove J, Amin R The effect of insulin intensification in children and young persons with Type 1 diabetes differs in relation to ethnic group; a prospective observational study. Diabet Med. 2013 Apr;30(4):495-501. doi: 10.1111/dme.12022.
Hamdan MA, Hempe JM, Velasco-Gonzalez C, Gomez R, Vargas A, Chalew S Differences in Red Blood Cell Indices Do Not Explain Racial Disparity in Hemoglobin A1c in Children with Type 1 Diabetes. J Pediatr. 2016 Sep;176:197-9. doi: 10.1016/j.jpeds.2016.03.068. Epub 2016 May 4.
Hanson CL, Henggeler SW, Burghen GA Race and sex differences in metabolic control of adolescents with IDDM: a function of psychosocial variables? Diabetes Care. 1987 May-Jun;10(3):313-8.
Hilliard ME, Rohan JM, Rausch JR, Delamater A, Pendley JS, Drotar D Patterns and predictors of paternal involvement in early adolescents' type 1 diabetes management over 3 years. J Pediatr Psychol. 2014 Jan-Feb;39(1):74-83. doi: 10.1093/jpepsy/jst067. Epub 2013 Sep 6.
Kamps JL, Hempe JM, Chalew SA Racial disparity in A1C independent of mean blood glucose in children with type 1 diabetes. Diabetes Care. 2010 May;33(5):1025-7. doi: 10.2337/dc09-1440. Epub 2010 Feb 25.
Khanolkar AR, Amin R, Taylor-Robinson D, Viner RM, Warner JT, Stephenson T Young people with Type 1 diabetes of non-white ethnicity and lower socio-economic status have poorer glycaemic control in England and Wales. Diabet Med. 2016 Nov;33(11):1508-1515. doi: 10.1111/dme.13079. Epub 2016 Feb 23.
Lord JH, Young MT, Gruhn MA, Grey M, Delamater AM, Jaser SS Effect of race and marital status on mothers' observed parenting and adolescent adjustment in youth with type 1 diabetes. J Pediatr Psychol. 2015 Jan-Feb;40(1):132-43. doi: 10.1093/jpepsy/jsu078. Epub 2014 Sep 23.
Markowitz JT, Volkening LK, Laffel LM Care utilization in a pediatric diabetes clinic: cancellations, parental attendance, and mental health appointments. J Pediatr. 2014 Jun;164(6):1384-9. doi: 10.1016/j.jpeds.2014.01.045. Epub 2014 Mar 6.
Saydah S, Imperatore G, Cheng Y, Geiss LS, Albright A Disparities in Diabetes Deaths Among Children and Adolescents - United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2017 May 19;66(19):502-505. doi: 10.15585/mmwr.mm6619a4.
Secrest AM, Becker DJ, Kelsey SF, LaPorte RE, Orchard TJ All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry. Diabetes Care. 2010 Dec;33(12):2573-9. doi: 10.2337/dc10-1170.
Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard TJ Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes. 2010 Dec;59(12):3216-22. doi: 10.2337/db10-0862. Epub 2010 Aug 25.
Service FJ, O'Brien PC The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial. Diabetologia. 2001 Oct;44(10):1215-20. Erratum in: Diabetologia. 2002 Jun;45(6):936..
Tull ES, Barinas E A twofold excess mortality among black compared with white IDDM patients in Allegheny county, Pennsylvania. Pittsburgh DERI Mortality Study Group. Diabetes Care. 1996 Dec;19(12):1344-7.
Wood CL, Clements SA, McFann K, Slover R, Thomas JF, Wadwa RP Use of Telemedicine to Improve Adherence to American Diabetes Association Standards in Pediatric Type 1 Diabetes. Diabetes Technol Ther. 2016 Jan;18(1):7-14. doi: 10.1089/dia.2015.0123. Epub 2015 Aug 21.
Wysocki T, Buckloh LM, Antal H, Lochrie A, Taylor A Validation of a self-report version of the diabetes self-management profile. Pediatr Diabetes. 2012 Aug;13(5):438-43. doi: 10.1111/j.1399-5448.2011.00823.x. Epub 2011 Oct 3.
Defining the Role of Management Factors in Outcome Disparity in Pediatric T1D
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.